SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-123841
Filing Date
2023-12-06
Accepted
2023-12-06 09:13:08
Documents
18
Period of Report
2023-12-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332212d1_8k.htm   iXBRL 8-K 45165
2 EXHIBIT 1.1 tm2332212d1_ex1-1.htm EX-1.1 52915
3 EXHIBIT 4.1 tm2332212d1_ex4-1.htm EX-4.1 85425
4 EXHIBIT 4.2 tm2332212d1_ex4-2.htm EX-4.2 87912
5 EXHIBIT 4.3 tm2332212d1_ex4-3.htm EX-4.3 87658
6 EXHIBIT 10.1 tm2332212d1_ex10-1.htm EX-10.1 227587
7 EXHIBIT 99.1 tm2332212d1_ex99-1.htm EX-99.1 11722
  Complete submission text file 0001104659-23-123841.txt   921789

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ibio-20231205.xsd EX-101.SCH 3012
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20231205_lab.xml EX-101.LAB 34240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20231205_pre.xml EX-101.PRE 22357
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2332212d1_8k_htm.xml XML 3194
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 231468580
SIC: 2834 Pharmaceutical Preparations